marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Aclaris Therapeutics Cash Flow 2011-2024 | ACRS
Annual Cash Flow Aclaris Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-78.3 M | -67.6 M | -52.1 M | -38.6 M | -96.4 M | -101 M | -54.7 M | -34.6 M | -20.4 M | - | - | - | - |
Depreciation & Amortization |
863 K | 797 K | 923 K | 1.32 M | 6.41 M | 1.88 M | 402 K | 120 K | 90 K | 12 K | 11 K | - | - |
Accounts Payables |
8.88 M | 10.4 M | 9.98 M | 5.25 M | 9.92 M | 14.8 M | 7.82 M | 2.84 M | 810 K | - | - | - | - |
Accounts Receivables |
298 K | 484 K | 623 K | 772 K | 704 K | 4.86 M | 481 K | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | 791 K | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Aclaris Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -20.8 M | - | - | - | -26.4 M | - | -48.5 M | - | -21 M | - | -35.1 M | - | -12.2 M | - | -29.8 M | -17.6 M | -6.8 M | - | -76.1 M | -52.7 M | -31.3 M | - | -73.6 M | -43.7 M | -21.9 M | - | -36.5 M | -22.7 M | -12.7 M | - | -26.5 M | -16.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
200 K | 200 K | 243 K | - | 200 K | 200 K | 198 K | - | 200 K | 200 K | 208 K | - | 726 K | 200 K | 288 K | - | 1.77 M | 1.18 M | 576 K | - | 6.09 M | 4.46 M | 2.23 M | - | 921 K | 537 K | 222 K | - | 221 K | 105 K | 50 K | - | 80 K | 27 K | 21 K | - | 32 K | 22 K | 3 K | - | 3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
7.66 M | 7.27 M | 10.8 M | 8.88 M | 9.65 M | 11.4 M | 8.19 M | 10.4 M | 7.67 M | - | 8.12 M | 9.98 M | 7.56 M | 4.24 M | 7.29 M | 5.25 M | 5.25 M | 5.25 M | 5.25 M | 9.92 M | 9.92 M | 9.92 M | 9.92 M | 11.7 M | 14.8 M | 14.8 M | 14.8 M | 7.82 M | 7.82 M | 7.82 M | 7.82 M | 2.84 M | 2.84 M | 2.84 M | 2.84 M | 810 K | 810 K | 810 K | 810 K | 1.26 M | 1.26 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
343 K | 325 K | 373 K | 298 K | 346 K | 431 K | 686 K | 484 K | 597 K | - | 633 K | 623 K | 811 K | 939 K | 817 K | 772 K | 772 K | 772 K | 772 K | 704 K | 704 K | 704 K | 704 K | 563 K | 563 K | 4.86 M | 4.86 M | 481 K | 481 K | 481 K | 481 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 189 K | 185 K | 856 K | 791 K | 791 K | 791 K | 791 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency